Eosinophilic inflammation in COPD

Date of Event:
2021-04-13 to 2021-04-14
Organiser:

The Soceity of Hospital Pharmacists of Hong Kong

Supporting Organisation:

AstraZeneca

Moderator:

N/A

Speaker:

Prof. Dave Singh

Dave Singh is professor of clinical pharmacology & respiratory medicine at the University of Manchester.  He graduated in medicine from Cambridge University and then specialised in clinical pharmacology and respiratory medicine. His research interest is the development of new drugs for asthma and COPD. He is the medical director of the Medicines Evaluation Unit, where he has acted as principal investigator in over 300 clinical trials. He is a member of the GOLD Science Committee. Currently, he is the chair of the European Respiratory Society airway pharmacology group, and an editor of the European Respiratory Journal and European Respiratory Review. He is a fellow of the European Respiratory Society and of the British Pharmacology Society. He has over 300 publications.

Agenda:

Apr 13th  2021 (Live)

08:00-09:00 GMT

English & Chinese

 

Apr 13th  2021 (Live)

22:00-23:00 GMT

English, French, Spanish & Portuguese

 

Apr 29th 2021 (Pre-recorded event)

19:00-20:00 HKT

English